Maria Symiakaki/ LinkedIn
May 29, 2026, 09:50
Maria Symiakaki: Advancing Cardiovascular Prevention at the 2026 Congress of the European Atherosclerosis Society
Maria Symiakaki, Co-Founder and Public Affairs Business Development Director at Solutions for Rare Diseases (SfRD), shared a post on LinkedIn:
“Happy to attend the 2026 Congress of the European Atherosclerosis Society.
It was an excellent opportunity for global leaders in lipidology and preventive cardiology to reconnect, exchange ideas, and explore the future of cardiovascular prevention and lipid management.
Key highlights included the release of the new EAS consensus on pediatric familial hypercholesterolemia (FH), as well as advances in global lipid clinic networks.
Importantly, patient voices continue to play a central role in shaping cardiovascular health policy and care pathways across Europe.”
Stay updated with Hemostasis Today.
-
Oct 20, 2026, 16:51Suzan Nakasendwa: A Growing Stroke Challenge in Uganda
-
Oct 20, 2026, 16:38Steve Moon: How Does Smoking Cessation Duration Affect Ischemic Stroke Risk
-
Oct 20, 2026, 16:25Cedrice Mentor: Reducing Platelet Wastage Through Cold Storage
-
Oct 20, 2026, 16:09Thirunavukkarasu Angappan: Can a Purified Fibrinogen Concentrate Replace Cryoprecipitate
-
Oct 20, 2026, 16:01Kalyan Roy: Platelet Conservation Through Evidence-Based Transfusion Practice
-
Oct 20, 2026, 15:28Stacy E. Croteau: 33 Countries, One Mission – Better Bleeding Disorder Care
-
Oct 20, 2026, 15:19Teresa Barnes: What Does a Pulmonary Embolism Mean for Jalen Hurts?
-
Oct 20, 2026, 15:04Laura S.: Could Speaking Up Prevent Maternal Deaths from Thrombosis?
-
Oct 20, 2026, 14:44Pete Stibbs: VTE in Professional Athletes – When Fitness Is Not Enough